World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
109
Citations
48613
World Ranking
5736
National Ranking
3085

Overview

Elliott Vichinsky is affiliated with the University of California, San Francisco, located in the United States. Their work primarily focuses on the field of Medicine, with significant contributions in Genetics, Hematology, and Pediatrics, Perinatology and Child Health, among other related subfields.

The scientist's research covers several specialized topics, including:

  • Hemoglobinopathies and Related Disorders
  • Iron Metabolism and Disorders
  • Blood groups and transfusion
  • Prenatal Screening and Diagnostics
  • Erythrocyte Function and Pathophysiology
  • Pharmacological Effects and Toxicity Studies
  • Pregnancy and preeclampsia studies

Vichinsky has published extensively, with notable frequent appearances in prominent journals including:

  • Blood
  • American Journal of Hematology
  • British Journal of Haematology
  • Blood Advances
  • UNC Libraries

Among recent published papers of relevance are:

  • American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults (2020, Blood Advances)
  • Voxelotor in adolescents and adults with sickle cell disease (HOPE): long-term follow-up results of an international, randomised, double-blind, placebo-controlled, phase 3 trial (2021, The Lancet Haematology)
  • Safety and efficacy of mitapivat, an oral pyruvate kinase activator, in adults with non-transfusion dependent α-thalassaemia or β-thalassaemia: an open-label, multicentre, phase 2 study (2022, The Lancet)
  • Variation in Neonatal Transfusion Practice (2021, The Journal of Pediatrics)
  • Effect of Inhaled Cannabis for Pain in Adults With Sickle Cell Disease (2020, JAMA Network Open)

Frequent collaborators in their research include:

  • Ashutosh Lal
  • Sylvia T. Singer
  • Amal El-Beshlawy
  • Angela Vitrano
  • Antonella Meloni

Best Publications

  • Prevention of a First Stroke by Transfusions in Children with Sickle Cell Anemia and Abnormal Results on Transcranial Doppler Ultrasonography

    R J Adams;V C McKie;L Hsu;B Files

  • Pain in sickle cell disease. Rates and risk factors.

    Orah S. Platt;Bruce D. Thorington;Donald J. Brambilla;Paul F. Milner

  • Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial.

    Gaston Mh;Verter Ji;Woods G;Pegelow C

  • Causes and Outcomes of the Acute Chest Syndrome in Sickle Cell Disease

    E P Vichinsky;L D Neumayr;A N Earles;R Williams

  • Effect of Hydroxyurea on Mortality and Morbidity in Adult Sickle Cell Anemia: Risks and Benefits Up to 9 Years of Treatment

    Martin H. Steinberg;Martin H. Steinberg;Franca Barton;Oswaldo Castro;Charles H. Pegelow

  • Sickle cell disease

    Gregory J Kato;Frédéric B Piel;Clarice D Reid;Marilyn H Gaston

  • Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease.

    Claudia R. Morris;Gregory J. Kato;Mirjana Poljakovic;Xunde Wang

  • Acute Chest Syndrome in Sickle Cell Disease: Clinical Presentation and Course

    Elliott P. Vichinsky;Lori A. Styles;Linda H. Colangelo;Elizabeth C. Wright

  • Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia

    Alexis A. Thompson;Mark C. Walters;Janet Kwiatkowski;John E.J. Rasko;John E.J. Rasko;John E.J. Rasko

  • Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative Study of Sickle Cell Disease.

    Frances M. Gill;Lynn A. Sleeper;Steven J. Weiner;Audrey K. Brown

  • Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood.

    E P Vichinsky;A Earles;R A Johnson;Hoag

  • Safety of Hydroxyurea in Children With Sickle Cell Anemia: Results of the HUG-KIDS Study, a Phase I/II Trial

    Thomas R. Kinney;Ronald W. Helms;Erin E. O’Branski;Kwaku Ohene-Frempong

  • Pulmonary complications of sickle cell disease.

    Mark T Gladwin;Elliott Vichinsky

  • A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease

    Elliott Vichinsky;Carolyn C. Hoppe;Kenneth I. Ataga;Russell E. Ware

  • The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up

    Martin H. Steinberg;William F. McCarthy;Oswaldo Castro;Samir K. Ballas

  • A Phase 3 Trial of l-Glutamine in Sickle Cell Disease.

    Yutaka Niihara;Scott T. Miller;Julie Kanter;Sophie Lanzkron

  • Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report

    Mark C. Walters;Rainer Storb;Melinda Patience;Wendy Leisenring

  • Newborn Screening for Sickle Cell Disease: Effect on Mortality

    Elliott Vichinsky;Deborah Hurst;Ann Earles;Klara Kleman

  • Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly Asian descent

    Sylvia T. Singer;Vivian Wu;Robert Mignacca;Frans A. Kuypers

  • Effect of Hydroxyurea on Mortality and Morbidity in Adult Sickle Cell Anemia

    Martin H. Steinberg;Franca Barton;Oswaldo Castro;Charles H. Pegelow

Frequent Co-Authors

Nancy F. Olivieri
Nancy F. Olivieri University of Toronto
John B. Porter
John B. Porter University College London
Frans A. Kuypers
Frans A. Kuypers UCSF Benioff Children's Hospital
Ellis J. Neufeld
Ellis J. Neufeld Boston Children's Hospital
Winfred C. Wang
Winfred C. Wang St. Jude Children's Research Hospital
Philippe Leboulch
Philippe Leboulch Brigham and Women's Hospital
John E.J. Rasko
John E.J. Rasko Centenary Institute of Cancer Medicine and Cell Biology
Bruce N. Ames
Bruce N. Ames University of California, Berkeley
William Klitz
William Klitz University of California, Berkeley
Robert J. Adams
Robert J. Adams Flinders University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn’t always mean following a traditional, lengthy path. There are a variety of fast track medical programs, such as online LPN and accelerated degree options, which allow students to enter the workforce quickly and efficiently.

For those interested in mental health, enrolling in an online psych np program is a flexible option. These programs help registered nurses advance their careers and specialize in psychiatric care, all while accommodating busy schedules.

Not all healthcare careers require patient care. If you want to work behind the scenes, earning the cheapest online health science degree can prepare you for vital roles in healthcare administration, coordination, or management.

For those aiming higher, a master's in healthcare administration online can open doors to leadership positions, offering advanced knowledge in policy, finance, and operations.

These pathways provide flexible, affordable alternatives to traditional medical degrees, giving you multiple options to launch or advance your career in healthcare.

Best Scientists Citing Elliott Vichinsky

Trending Scientists

Recently Published Articles